Granted claims cover the use of vafidemstat for treating non-aggressive symptoms of BPD U.S. patent to expire in March 2043, including 1,095 days ...

Leading US psychiatric experts join Oryzon’s Clinical Advisory Board (CAB) to advance Phase III development of vafidemstat in Borderline Personality Disorder (BPD) CAB and Oryzon establish primary and ...

Suicide risk is the most significant consideration in the treatment of psychiatric disorders. Suicidal behavior has significantly increased over the last decade, and preliminary studies suggest it has ...

Here's what BPD is, what causes it, how it is treated and why there is hope for those who have it.

Borderline personality disorder (BPD) is a serious mental health condition that affects the way people think about themselves ...

Borderline personality disorder (BPD) is a type of mental illness that hinders a person’s ability to manage their emotions. People with this condition may experience overreactions to certain triggers, ...

Where mood disorders can cause temporary or fluctuating changes in mood, personality disorders cause symptoms that remain consistent over time and across a range of situations. For example, bipolar ...